Mortality 'significantly' increased in 2nd Covid wave in India: Study

The second Covid wave in India was slightly different than the first one, with higher mortality being reported in all age groups except those below 20 years

Coronavirus, Covid-19 deaths, Covid-19
Press Trust of India New Delhi
3 min read Last Updated : Jul 03 2021 | 10:08 PM IST

The second Covid wave in India was slightly different than the first one, with higher mortality being reported in all age groups except those below 20 years, and more people developing acute shortness of breath and requiring supplemental oxygen and mechanical ventilation, a new study said on Saturday.

The study - Clinical profile of hospitalized COVID-19 patients in first and second wave of the pandemic: Insights from an Indian registry based observational study - was published in the Indian Journal of Medical Research and has been done by experts from the Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences and National Centre for Disease Control (NCDC).

India witnessed a massive second surge of COVID-19 cases since March after a period of decline from September last year.

Data collected under the National Clinical Registry for COVID-19 (NCRC) were analysed to describe the differences in demographic and clinical features of COVID-19 patients recruited during these two successive waves, the study stated.

The NCRC, launched in September last year, is an ongoing multi-centre observational initiative, which provided the platform for the current investigation.

Demographic, clinical, treatment and outcome data of hospitalized and confirmed COVID-19 patients were captured in an electronic data portal from 41 hospitals across India, it said.

Patients enrolled between September 1, 2020 and January 31, 2021 and February 1 to May 11, 2021 constituted the participants of the two successive waves respectively, it said.

As on May 11 this year, 18,961 individuals were recruited in the registry, 12,059 and 6,903 reflecting in-patients from the first and second waves respectively, it said.

The mean age of the patients was significantly lower in the second wave with higher proportion of patients in the younger age group intervals of less than 20 years, and 20-39 years, the study said.

It said approximately 70 per cent of the admitted patients were above 40 years in both the waves of the pandemic and the proportion of males were slightly lower in second wave as compared to the first.

The most common symptom was fever in both the waves, it said.

"In the second wave, a significantly higher proportion complained of shortness of breath, developed acute respiratory distress syndrome (ARDS), required supplemental oxygen and mechanical ventilation.

"Mortality also was significantly increased in the second wave in all age groups except in below 20 years," it said.

"The second wave of COVID-19 in India was slightly different in presentation than the first wave, with a younger demography, lesser comorbidities, and presentation with breathlessness in greater frequency," the study stated.

Noting that there were some limitations of the present investigation, it said the registry did not capture the initial phase of the first wave as data collection commenced from September 1, 2020.

There has been a considerable lag in obtaining a complete dataset due to time required for data verification and the unprecedented workload of the healthcare team involved in COVID-19 care. Hence, the outcome data were not available for many cases from the second wave, the study said.

Though the data was submitted from more than 40 hospitals across the country to the NCRC, data from some states like Maharashtra and Kerala were missing due to logistical reasons, thus constraining the national representation, it said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelta variant of coronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jul 03 2021 | 10:08 PM IST

Next Story